„biocon valley – the cluster in life science and health ...€žbiocon valley – the cluster in...
TRANSCRIPT
„BioCon Valley – the Cluster in Life Science and Health, Mecklenburg-Vorpommern, Germany“
Moscow, April 23rd, 2013Dr. Heinrich Cuypers, Senior Project Manager BioCon Valley
Megatrends
Mechanization(Steel, Railway)
Elektrification(e-technik, Chemistry)
Automotive(Oil, Petrochemie,
Auto)
Digitalisization(Computer, Internet, Handy)
Biologization
1900 1950 1980 2000 2010
„Die langen Wellen der Konjunktur“, Kondratieff, 1926 Berlin; Leo A. Nefiodow , 1990
1 to Steel= 1.000 €
1 to Steel= 50.000 €
1 to Insulin= 10.000.000.000 €
© BioCon Valley® GmbH · Greifswald / Rostock
Impact of Life Science – Woman in the Age of 63
Dürers Mother (1514)
e.g. Sophia Loren (1997)
…and it is a big market too !
…because of- modern medicine- healthy nutrition- clean environment
© BioCon Valley® GmbH · Greifswald / Rostock
Definition Biotechnology ClusterCritical factors for development*1. Strong science base (R&D)2. Entrepreneurial culture3. Growing company base4. Ability to attract key staff5. Availability of finance6. Premises and infrastructure (e.g. Bioincubators)7. Business support services and large companies in related
industries8. Skilled workforce9. Effective networks10.Supportive policy environment
*source: “BIOTECHNOLOGY CLUSTERS”, Report of a team led by Lord Sainsbury, Minister for Science UK, August 1999; http://www.dti.gov.uk/biotechclusters/
© BioCon Valley® GmbH · Greifswald / Rostock
23.04.2013 5
German BioRegionshot spots for biotech industry since 1996
© BioCon Valley® GmbH · Greifswald / Rostock
Biotech in Germany – catching upe.g.: No of new drugs in development („pipeline“), clinical phase I – III
28
5
5
6
7
14
18
19
20
28
128
Andere
Niederlande
Finnland
Deutschland
Italien
Israel
Schweden
Frankreich
Schweiz
Dänemark
UKFigure b: 2011
Figure a: 2001
Source: Ernst & Young
21
36
79
61
82
121
118
125
142
218
Finnland
Niederl…
Italien
Israel
Schwe…
Schweiz
Frankre…
Dänem…
Deutsc…
UK
© BioCon Valley® GmbH · Greifswald / Rostock
• Number of employees ~ 97.500• Gross value added ~ 4 bio. €• > 120 life sciences companies (biotech, medtech, pharma)• 2 universities with focus on life sciences and health (2 univ. hospitals)• 3 universities of applied sciences, 5 federal or regional research
institutes, > 20 centres of competence• More than 60 modern hospitals and rehabilitation clinics
(> 12.000 beds)• Tradition in spa and wellness tourism with
– more than 255 star rated hotels and spas (> 50% 4 star +)– 54 audited health and recreation resorts („Kurort“)
• Regional agenda (Masterplan) for Health Economy• Kuratorium Gesundheitswirtschaft (appointed by prime minister)
Health Economy in MV– key figures
© BioCon Valley® GmbH · Greifswald / Rostock 7
Health CarePrimary sector
Masterplan Gesundheitswirtschaft 2020A Vision for Mecklenburg-Vorpommern in 2020
© BioCon Valley® GmbH · Greifswald / Rostock 8
LifeSciences
HealthyFood
HealthTourism
HealthyAgeing 10 year strategic agenda
Projects focussing on cross-sectoral approaches Kuratorium as „triple-helix“
advisory body
HealthServices
Challenges
• Rural area• Low industrialization
(low GDP, no „big“-enterprises, ...)
• Remote location (in Germany)
Potentials
- Strong research & development- Dynamic enterprises (SME)- Modern infrastructure
(technology centers, hospitals)- Active network- International platform
• Life Sciences• Health Care
BioCon Valley: The Region
Greifswald
Schwerin
Northern Germany Population ca.
1,8 Mio. (= Hamburg) Size ca. 23.000 km² Ca. 80 inhabitants / km² Rostock biggest city
(200.000 inhabitants) > 1.000 km coastline
Economical focus• Maritime industry• Agriculture• Tourism
Moscow
Rostock
Copenhagen
Berlin
© BioCon Valley® GmbH · Greifswald / Rostock
Research and Development
Research and development inLife Sciences at
- 2 universities(Rostock 1419, Greifswald 1456)
- 3 universities of applied science- 5 non universitary federal or
regional research institutions- 16 more centers of competence
within life sciences
• approx 3.000employees in R&D
• approx. 6.430 students(total approx. 38.000)
• approx. 90 Mio. € p.a.in life sciences R&D
e.g. Universität Rostock e.g. Universität Greifswald
e.g. Fachhochschule Neubrandenburg
e.g. FachhochschuleStralsund
GreifswaldRostock
© BioCon Valley® GmbH · Greifswald / Rostock
Core Competences in R&D
Marine Biotechnology- Screening for new
bioactive compounds- Aquaculture- „FunGene“
Medical Biotechnology- Molecular Medicine- Regenerative Medicine- Medical Technology
Agrobiotechnology- Plant development,
plant breeding- Animal health,
animal breeding
Other Biotechnologies- Life Science Automation- Bioanalytics- Bioinformatics- Food applications
© BioCon Valley® GmbH · Greifswald / Rostock
Case Studies – Applied Research, e.g.• „BIOKATALYSE2021 Novel approaches to a sustainable industrial «white»
biotechnology” (2007-2012); www.biokatalyse2021.de
• „PHENOMICS – Network of Competence of Agricultural and Nutritional Research on Farm Animals“ (2010-2015)www.phaenomics.auf.uni-rostock.de
• „HICARE – Alliance against Mulit-resistant Bacteria: National Health Region Baltic Sea Coast“ (2011-2015)http://hicare.de
• „CELISCA – Center for Life Science Automation“ (2012-2017)www.celisca.de/
• „REMEDIS – The implant technology of the future” (2009-2013) http://remedis.med.uni-rostock.de/
• „GANI_MED – Greifswald Approach to Individualized Medicine” (2009-2013) www.medizin.uni-greifswald.de/gani_med
> Complete Mapping: CD-ROM based BioCon Valley® - directory, 8th ed 2011
© BioCon Valley® GmbH · Greifswald / Rostock
Case Studies – Companies, e.g.• Cortronik GmbH & Co KG, 180 jobs biocompatible implants
www.cortronik.de (“stents”)
• DECODON GmbH, Greifswald, 12 jobs bioinformatic for functional genomicswww.decodon.com
• DOT GmbH, 235 Jobs coating implants, reg.med.www.dot-coating.de (orthopedic)
• Miltenyi Biotec GmbH, TET, 180 jobs enabling technologies,www.miltenyibiotech.de cell charact. & isolation
• DST GmbH fast allergy test systems (pats, cattle, www.dst.com dust, nutrition ingredients,
• NPZ Saatzucht Hans Lembke KG, 170 jobs plant breeder (canola, clover)www.npz.de
• Riemser Arzneimittel AG, 650 jobs pharma (cancer, derma, vet.)www.riemser.de
> Complete Mapping: CD-ROM based BioCon Valley® - directory, 8th ed 2011:
© BioCon Valley® GmbH · Greifswald / Rostock
Biotech Incubators and Parks
Rostock
Teterow
Berlin
Ham
burg
A20
A19
A24
Neubrandenburg
Biotech incubators
Biotech park
Biomedizin-Technikum Teterow (3)
AgroBioTechnikumGroß Lüsewitz (4)
BioTechnikum Greifswald (2)
Greifswald
Zentrum für Lebensmittel-technologie
BiomedizinischesForschungszentrum
Forschungszentrum Biosystemtechnik undBiomaterialien (1)
2 3 41
Enterprises, Life Science
Formation ofcompanies. First phase 92/93. Second Phase 97/00
120 Enterprises ~ 3.600 Employees Medium sized
companies, e.g.. DOT GmbH. Envitec GmbH. Gambro Rostock GmbH. Hoffrichter. Miltenyi Biotec GmbH. Riemser Arzneimittel AG
020406080
100120140
1997
2000
2002
2004
2006
2008
2010
2012
No.
of c
ompa
nies
05001000150020002500300035004000
No.
of j
obs
No. of companies No. of jobs
Multilayer modelHealth Economy
16
Core sectorInpatient and outpatient treatment
Secondary sector(Administration,pharmacies, Spa andrehabilitation, patient organisations)
Health care related industries(Bio-/Medtech, Pharma, Handicraft, …)
Related and neighbouring sectors(sports, tourism and others)
Employees
Gross value added (Mrd. €)
97.500
~ 3,5 – 4,0
MV
Source: PD Dr. J. Hilbert, IAT Gelsenkirchen
© BioCon Valley® GmbH · Greifswald / Rostock
Health Economyfrom a regional viewpoint
© BioCon Valley® GmbH · Greifswald / Rostock 17
Bundesland Rang AM*-Anteil in %2006
Rang 1996
Differenz1996-2006
Berlin 1 15,8 1 +2,0Mecklenburg-Vorpommern 2 15,1 2 +2,1
Sachsen-Anhalt 3 14,6 7 +2,2Brandenburg 4 14,2 9 +2,2
Schleswig-Holstein 5 14,1 3 +1,2
Datenquellen: Destatis, 2009; BA 2009; Berechnung: Wertschöpfungsansatz, WifOR, 2010.
Driver for employment
*AM: Arbeitsmarkt
Tasks:– Bundle and align regional interests and forcees in
life sciences and health (triple helix-model)– Stimulate cooperation between companies, research
& development and health care providers– Foster international marketing and collaboration
Shareholders:– Federal State Mecklenburg-Vorpommern– BioCon Valley Mecklenburg-Vorpommern e.V.
(~160 members)– 4 financial institutions, 2 private shareholders
2 locations (Greifswald and Rostock)with presently 20+ employees
BioCon Valley® GmbH– cluster management
© BioCon Valley® GmbH · Greifswald / Rostock 18
Networking national & international
National: BioCon Valley is member of the German
BioRegions; www.biodeutschland.org/ak-bioregio.htmlwww.biotechnologie.de
International: BioCon Valley is cofounder of ScanBalt – the
network of Life Science and health networks in Northern Europe, i.e. Denmark, Estonia, Finland, Iceland, Latvia, Lithuania, Norway, Poland, Sweden, North-West Russia; www.scanbalt.org
23.04.2013 19
• ScanBalt– ScanBalt Chairmanship– ScanBalt Bridge-BSR– Involvement in new syndicates on demand
• Poland– Poln.-Dt. Life Science Forum– South Baltic Cross Border Programme project „Eco4Life“
• Russia:– German-Russian Cooperation Network for Biotechnology
• Arabic Countries– Arab Health– Tunesien
• Indien– Participation on the project of the Netzwerk Deutsche Gesundheitsregionen e.V.
(R&D-Marketing Life SciencePlus Indien)• USA
– Participation on a official visit of the State Minister of Economy• Asia (Japan, Vietnam)
– Biotech-Newsletter Japan– Support of the current activities in Vietnam (Univ. Greifswald, ScanBalt)
International Projects
20
Benefit for Economy and Research Information about international
markets Chance for contacts and cooperations Market entry Marketing for companies and location
Projects www.scanbalt.org and ScanBalt News Regional Portraits Industry Opinions Meetings, partnering, events Ongoing strategy discussion Competence mapping and cluster
analysis Strategic communication Strategic partnerships
ScanBalt Health Region (EU flagship) Eco4Life (EU) ScanBalt Campus (EU ScanBalt Network of Networks
(Nordic Inno Centre) ScanBalt Competence Region (EU) Boosting Baltic FP6 (EU) Educational mobility
(Nordic Inno Centre) Economic Barriers for Borderless
Cooperation (Nordic Inno Centre) Biotech, one click away
(Nordic Inno Centre)
Creating Infrastructure
BSHR Healthport (EU) Submariner (EU) Baltic Amber (DLR) ScanBalt IP-Knowledge Center (EU) ScanBalt Marine Biotech (NorForsk) ScanBalt Clinical Research Network
(Nordic Innovation Centre) ScanBalt AgroBiotech (NorForsk) ScanBalt Stem Cell Network (NorForsk) ScanBalt Biofuel Network
(Nordic Innovation Centre)
Thematic Focus
Communication and Visibility
e.g. EU BSR Flagship Project „ScanBalt Health Region“
Objectives:− … promotion of public health on a high level− … exploitation of modern health and life sciences− … innovations in science, technology and social science− Baltic Sea Region as a model for a knowledge-based economy
and for implementing a shared strategy Lead Partners:
− BioCon Valley (Germany)− Lithuanian Biotechnology Association (Lithuania)− ScanBalt and ScanBalt Academy (ScanBalt BioRegion)
More: http://www.balticsea-region-strategy.eu/www.scanbalt.org
Set up cross-sectoral reference projects for innovation in health and life sciences
Health Economy…some trends
© BioCon Valley® GmbH · Greifswald / Rostock 24
Health &Medical
Wellness
Source: Der Spiegel, 2008
Service oriented industries
Source:www.keinfastfood.de
Agriculture
Source: NY Times, 2008
German-Russian Forum Biotechnology, Rostock 2013Date: June, 4.-5, 2013Venue: Rostock, GermanyScope: The German-Russian Cooperation Network Biotechnology aims to
deepen, strengthen and to enhance the existing contacts between German and Russian biotechnology companies, research institutions and decision makers in policy and administrations.
Day one: workshops (e.g. bioinformatics, industrial biotech, regenerative and personalized medicine, marine biotech)
Day two: study tour to companies and research institutes
More: http://www.owwz.de/rostock.html
23.04.2013 25